PIP and ischemia: In this study, we first conducted in vivo experiments and found that GP17 administration significantly ameliorated neurological dysfunction induced by MCAO/R, reduced the cerebral infarct volume, alleviated the pathological changes in brain tissue caused by ischemia, and inhibited oxidative damage and inflammatory responses during acute cerebral ischemia.